{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:46:49Z","timestamp":1790700409678,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003065","name":"Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.heliyon.2021.e06605","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T23:22:09Z","timestamp":1617319329000},"page":"e06605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0970-1060","authenticated-orcid":false,"given":"Nathalie","family":"Moussa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Gharaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2021.e06605_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/157340607781745393","article-title":"6-Aryl-4-oxohexanoic acids: synthesis, effects on eicosanoid biosynthesis, and anti-inflammatory in vivo-activities","volume":"3","author":"Abouzid","year":"2007","journal-title":"Med. Chem."},{"issue":"20","key":"10.1016\/j.heliyon.2021.e06605_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/chin.200320245","article-title":"Cyclooxygenase-1\/2 (COX-1\/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type","volume":"34","author":"Ulbrich","year":"2003","journal-title":"ChemInform"},{"issue":"11","key":"10.1016\/j.heliyon.2021.e06605_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2174\/0929867003374237","article-title":"Structural approaches to explain the selectivity of COX-2 inhibitors: is there a common pharmacophore?","volume":"7","author":"Dannhardt","year":"2000","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06605_bib4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bmc.2004.01.027","article-title":"Computational studies of COX-2 inhibitors: 3D-QSAR and docking","volume":"12","author":"Kim","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e06605_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/jm0009383","article-title":"Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo [1,5-a] pyrimidines","volume":"44","author":"Almansa","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e06605_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06605_bib7","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1073\/pnas.94.7.3336","article-title":"Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential","volume":"94","author":"Tsujii","year":"1997","journal-title":"PNAS USA"},{"key":"10.1016\/j.heliyon.2021.e06605_bib8","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2174\/138161208784480153","article-title":"Nonsteriodal anti-inflammatory drugs in experimental Parkinsonian models and Parkinson\u2019s disease","volume":"14","author":"Asanuma","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2021.e06605_bib9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM200111223452110","article-title":"Do nonsteroidal anti inflammatory drugs reduce the risk of Alzheimer's disease?","volume":"345","author":"Breitner","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e06605_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-2006-9S330","article-title":"Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years","volume":"9","author":"McGeer","year":"2006","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/molecules25010220","article-title":"Synthesis of novel benzodifuranyl; 1,3,5-triazines; 1,3,5-oxadiazepines; and thiazolopyrimidines derived from visnaginone and khellinone as anti-inflammatory and analgesic agents","volume":"25","author":"Abu-Hashem","year":"2020","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.heliyon.2021.e06605_bib12","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3390\/molecules24203663","article-title":"Design, synthesis and investigation of the potential anti-inflammatory activity of 7-O-amide hesperetin derivatives","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06605_bib13","doi-asserted-by":"crossref","first-page":"115403","DOI":"10.1016\/j.bmc.2020.115403","article-title":"Novel class of benzimidazole-thiazole hybrids: the privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes","volume":"28","author":"Maghraby","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e06605_bib14","first-page":"103438","article-title":"New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: design, synthesis, selective COX-2, DHFR and molecular-modeling study","volume":"99","author":"Hanafy Metwally","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.heliyon.2021.e06605_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21655","article-title":"Synthesis of novel N-substitutedphenyl-6-oxo-3-phenylpyridazine derivatives as cyclooxygenase-2 inhibitors","author":"Khan","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e06605_bib16","doi-asserted-by":"crossref","first-page":"1900293","DOI":"10.1002\/ardp.201900293","article-title":"Design, synthesis, and biological evaluation of new 1,4-diarylazetidin-2-one derivatives (\u03b2-lactams) as selective cyclooxygenase-2 inhibitors","volume":"353","author":"Arefi","year":"2020","journal-title":"Archiv Der Pharmazie"},{"issue":"11","key":"10.1016\/j.heliyon.2021.e06605_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/biom9110661","article-title":"Novel series of methyl 3-(substituted benzoyl)-7-substituted-2-phenylindolizine-1-carboxylates as promising anti-inflammatory agents: molecular modeling studies","volume":"9","author":"Venugopala","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.heliyon.2021.e06605_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.phrs.2010.02.007","article-title":"Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation","volume":"61","author":"Cao","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2021.e06605_bib19","first-page":"1","article-title":"Complementary and alternative medicine use among adults: United States, 2002","volume":"343","author":"Barnes","year":"2004","journal-title":"Adv. Data"},{"key":"10.1016\/j.heliyon.2021.e06605_bib20","series-title":"Bioactive Compounds from Natural Sources","first-page":"98","author":"Tringali","year":"2001"},{"key":"10.1016\/j.heliyon.2021.e06605_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural products as sources of new drugs over the last 25 years","volume":"70","author":"Newman","year":"2007","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.heliyon.2021.e06605_bib22","series-title":"Herbs and Natural Supplements an Evidence-Based Guide","author":"Lesley","year":"2010"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e06605_bib23","first-page":"165","article-title":"Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach","volume":"171","author":"Kapetanovic","year":"2008","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.pa.27.040187.001205","article-title":"Computer-aided drug design","volume":"27","author":"Marshall","year":"1987","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06605_bib25","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e06605_bib26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/molecules25061375","article-title":"A\u00a0review on applications of computational methods in drug screening and design","volume":"25","author":"Lin","year":"2020","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.heliyon.2021.e06605_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recogn. Lett."},{"key":"10.1016\/j.heliyon.2021.e06605_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biosystems.2017.09.005","article-title":"Toward a hierarchical virtual screening and toxicity risk analysis for identifying novel CA XII inhibitors","volume":"162","author":"Elmira","year":"2017","journal-title":"Biosystems"},{"key":"10.1016\/j.heliyon.2021.e06605_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/qsar.200390007","article-title":"The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models","volume":"22","author":"Tropsha","year":"2003","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.heliyon.2021.e06605_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.heliyon.2021.e06605_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymeth.2014.10.013","article-title":"Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling","volume":"71","author":"Vuorinen","year":"2015","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Gerhard","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.heliyon.2021.e06605_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biosystems.2013.12.002","article-title":"Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer\u2019s agents","volume":"116","author":"Ambure","year":"2014","journal-title":"Biosystems"},{"issue":"14","key":"10.1016\/j.heliyon.2021.e06605_bib34","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"issue":"23","key":"10.1016\/j.heliyon.2021.e06605_bib35","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1021\/jm0608356","article-title":"Benchmarking sets for molecular docking","volume":"49","author":"Huang","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e06605_bib36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/ci400037y","article-title":"Highly specific and sensitive pharmacophore model for identifying CXCR4 antagonists. Comparison with docking and shape-matching virtual screening performance","volume":"53","author":"Karaboga","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1758-2946-5-2","article-title":"Enhanced ranking of PknB Inhibitors using data fusion methods","volume":"5","author":"Seal","year":"2013","journal-title":"J.\u00a0Cheminf."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e06605_bib38","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s00044-012-0227-3","article-title":"New molecular scaffolds for the design of Alzheimer\u2019s acetylcholinesterase inhibitors identified using ligand-and receptor-based virtual screening","volume":"22","author":"Chitranshi","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1423-0127-18-8","article-title":"The discovery of potential acetylcholinesterase inhibitors: acombination of pharmacophore modeling, virtual screening, and molecular docking studies","volume":"18","author":"Lu","year":"2011","journal-title":"J.\u00a0Biomed. Sci."},{"issue":"12","key":"10.1016\/j.heliyon.2021.e06605_bib40","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/aps.2009.159","article-title":"Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets","volume":"30","author":"Chen","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"issue":"9","key":"10.1016\/j.heliyon.2021.e06605_bib42","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.bmcl.2013.02.107","article-title":"Molecular design, synthesis and biological evaluation of cyclic imides bearing benzene sulfonamide fragment as potential COX-2 inhibitors. Part 2","volume":"23","author":"Al-Suwaidan","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.heliyon.2021.e06605_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmech.2014.12.039","article-title":"Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities","volume":"92","author":"Alanazi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e06605_bib44","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.ejmech.2011.02.013","article-title":"Synthesis, anti-inflammatory activity and COX-1\/COX-2 inhibition of novel substituted cyclic imides. Part 1: molecular docking study","volume":"46","author":"Abdel-Aziz","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.heliyon.2021.e06605_bib45","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1016\/j.bmc.2007.08.057","article-title":"A\u00a0novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine","volume":"15","author":"Fatemi","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2021.e06605_bib46","unstructured":"MATLAB. MATLAB, Version 7. The MathWorks, Inc., Natick, MA."},{"key":"10.1016\/j.heliyon.2021.e06605_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/qsar.200710043","article-title":"On some aspects of variable selection for partial least squares regression models","volume":"27","author":"Roy","year":"2008","journal-title":"QSAR Comb. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2021.e06605_bib50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/1062936X.2013.792877","article-title":"Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors","volume":"24","author":"Gharaghani","year":"2013","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.heliyon.2021.e06605_bib51","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1021\/ci010290i","article-title":"Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration","volume":"41","author":"Liu","year":"2001","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.heliyon.2021.e06605_bib52","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/138161207782794257","article-title":"Predictive QSAR modeling workflow model applicability domains and virtual screening","volume":"13","author":"Tropsha","year":"2007","journal-title":"Curr. Pharmaceut. Des."},{"issue":"16","key":"10.1016\/j.heliyon.2021.e06605_bib53","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm060522a","article-title":"Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring","volume":"49","author":"Lyne","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J.\u00a0Chem. Theor. Comput."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00117280","article-title":"Class IV charge models: a new semi empirical approach in quantum chemistry","volume":"9","author":"Storer","year":"1995","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.heliyon.2021.e06605_bib58","series-title":"Maestro 9.9","year":"2019"},{"issue":"3","key":"10.1016\/j.heliyon.2021.e06605_bib59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi","year":"2013","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"issue":"13","key":"10.1016\/j.heliyon.2021.e06605_bib60","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1002\/jcc.21859","article-title":"Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime\/MMGBSA calculation","volume":"32","author":"Du","year":"2011","journal-title":"J.\u00a0Comput. Chem."},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06605_bib61","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"21","key":"10.1016\/j.heliyon.2021.e06605_bib62","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and dcoring incorporating amodel of hydrophobic enclosure for protein\u2212ligand complexes","volume":"49","author":"Halgren","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06605_bib63","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"12","key":"10.1016\/j.heliyon.2021.e06605_bib65","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/ci300363c","article-title":"Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e06605_bib66","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1093-3263(00)00040-1","article-title":"Docking of sulfonamides to carbonic anhydrase II and IV","volume":"18","author":"Esposito","year":"2000","journal-title":"J.\u00a0Mol. Graph. Model."},{"issue":"11","key":"10.1016\/j.heliyon.2021.e06605_bib67","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","article-title":"Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2","volume":"3","author":"Luong","year":"1996","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06605_bib68","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.0909765106","article-title":"Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1","volume":"107","author":"Rimon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06605_bib69","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies. [Review]","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"6460","key":"10.1016\/j.heliyon.2021.e06605_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"issue":"52","key":"10.1016\/j.heliyon.2021.e06605_bib71","doi-asserted-by":"crossref","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","article-title":"Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and \u22122","volume":"271","author":"Smith","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"issue":"10","key":"10.1016\/j.heliyon.2021.e06605_bib72","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1107\/S2053230X16014230","article-title":"Crystal structure of rofecoxib bound to human cyclooxygenase-2","volume":"72","author":"Orlando","year":"2016","journal-title":"Acta Crystallogr. F"},{"key":"10.1016\/j.heliyon.2021.e06605_bib75","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ejca.2005.05.009","article-title":"Curcumin: the story so far","volume":"41","author":"Sharma","year":"2005","journal-title":"Eur. J. Canc."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e06605_bib76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/10408390903584094","article-title":"Effects of flavonoids and other polyphenols on inflammation","volume":"51","author":"Gonz\u00e1lez","year":"2011","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e06605_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jep.2010.05.015","article-title":"Free radical scavenging activities and inhibition of inflammatory enzymes of phenolics isolated from Tripodanthus acutifolius","volume":"130","author":"Sober\u00f3n","year":"2010","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e06605_bib78","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-2006-957506","article-title":"Flavan-3-ols isolated from some medicinal plants inhibiting COX-1 and COX-2 catalysed prostaglandin biosynthesis","volume":"64","author":"Noreen","year":"1998","journal-title":"Planta Med."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e06605_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.923","article-title":"Bioactive compounds from natural sources isolation, characterization and biological properties","volume":"16","author":"Gibbons","year":"2002","journal-title":"Phytother Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021007088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021007088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:19:35Z","timestamp":1752581975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021007088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2405844021007088"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06605","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e06605"}}